Enovis Corp (ENOV)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $1.60B
Last updated: Nov 17, 2026 at 11:05 AM ET
Enovis Corp (ENOV) P/E Ratio & Valuation History
Enovis (ENOV) trades at 8.3x trailing earnings and 0.7x sales. Its P/E of 8.3x is below its 5-year median of 13.7x. Its forward P/E is 7.7x. The median P/E across 6 similar companies is 30.5x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 7.8% higher over the next year. Its free cash flow yield is 4.3%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 8.3x |
| Forward P/E | 7.7x |
| Price to sales | 0.7x |
| Price to book | 1.1x |
| Price to FCF | 23.2x |
| EV/FCF | 41.9x |
| PEG | 1.9 |
| FCF yield | 4.3% |
Historical Medians
Against its 10-year medians, its P/E is 34.1% below 12.6x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 8.3x | 13.7x | 12.6x |
| P/B | 1.1x | 0.8x | N/A |
Valuation History
Over the 10 year ends shown, its P/E ranged from 5.2x in 2018 to 23.6x in 2022.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $26.64 | 8.1x | 0.7x | 1.0x |
| 2024 | $43.88 | 15.5x | 1.2x | 1.0x |
| 2023 | $56.02 | 23.3x | 1.8x | 0.9x |
| 2022 | $53.52 | 23.6x | 1.9x | 0.8x |
| 2021 | $79.12 | 12.4x | N/A | N/A |
| 2020 | $65.82 | 15.8x | N/A | 0.5x |
| 2019 | $62.62 | 9.6x | N/A | N/A |
| 2018 | $35.97 | 5.2x | N/A | 0.3x |
| 2017 | $68.19 | 13.8x | 5.0x | 0.5x |
| 2016 | $61.84 | 13.2x | N/A | 1.5x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ENOV
What is ENOV's forward P/E ratio?
Enovis has a forward P/E ratio of 7.7x.
Is ENOV stock overvalued?
GNG's valuation label for ENOV is Undervalued. Its P/E of 8.3x compares with a median of 30.5x across 6 similar companies.
What is ENOV's price to sales ratio?
Enovis has a price to sales ratio of 0.7x.
What is Enovis's average P/E ratio over 5 years?
Enovis's median P/E over the last 5 years is 13.7x, from 60 month-end values through Oct 2026.
What is ENOV's PEG ratio?
Enovis has a PEG ratio of 1.9.
ENOV pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors